...
首页> 外文期刊>Science China Life Sciences >Inter-chain disulfide bond improved protein trans-splicing increases plasma coagulation activity in C57BL/6 mice following portal vein FVIII gene delivery by dual vectors
【24h】

Inter-chain disulfide bond improved protein trans-splicing increases plasma coagulation activity in C57BL/6 mice following portal vein FVIII gene delivery by dual vectors

机译:链间二硫键改善的蛋白质转拼增加了通过双载体递送门静脉FVIII基因后C57BL / 6小鼠的血浆凝血活性

获取原文
获取原文并翻译 | 示例
           

摘要

Protein trans-splicing based dual-vector factor VIII (FVIII) gene delivery is adversely affected by less efficiency of protein splicing. We sought to increase the amount of spliced FVIII protein and plasma coagulation activity in dual-vector FVIII transgene in mice by means of strengthening the interaction of inteins, protein splicing elements, thereby facilitating protein trans-splicing. Dual-vector delivery of the FVIII gene in cultured cells showed that replacement of Met226 in the heavy chain and Asp1828 in the light chain with Cys residues could facilitate inter-chain disulfide linking and improve protein trans-splicing, increasing the levels of spliced FVIII protein. In this study, C57BL/6 mice were coadministered dual vectors of intein-fused human FVIII heavy chain and light chain with Cys mutations via portal vein injection into the liver. Forty-eight hours post-injection, plasma was collected and analyzed for FVIII antigen concentration and coagulation activity. These mice showed increased circulating FVIII heavy chain polypeptide (442±151 ng mL−1 vs. 305±103 ng mL−1) and coagulation activity (1.46±0.37 IU m−1 vs. 0.85±0.23 IU mL−1) compared with control mice co-administered dual vectors expressing the heavy and light chains of wild-type FVIII. Moreover, coagulation activity was similar to that of mice receiving a single vector expressing FVIII (1.79±0.59 IU mL−1). These findings indicate that improving protein trans-splicing by inter-chain disulfide bonding is a promising approach for increasing the efficacy of dual-vector based FVIII gene transfer.
机译:基于蛋白质转拼的双载体因子VIII(FVIII)基因传递受到蛋白质剪接效率较低的不利影响。我们试图通过加强内含蛋白,蛋白质剪接元件的相互作用,从而促进蛋白质的反剪接,来增加小鼠双载体FVIII转基因中剪接的FVIII蛋白的量和血浆凝固活性。 FVIII基因在培养细胞中的双载体递送显示,用Cys残基取代重链中的Met226和轻链中的Asp1828可以促进链间二硫键连接并改善蛋白反式剪接,从而增加了剪接的FVIII蛋白的水平。在这项研究中,将C57BL / 6小鼠通过门静脉注射到肝脏中,与带有Cys突变的内含蛋白融合的人FVIII重链和轻链双重载体共同给药。注射后48小时,收集血浆并分析FVIII抗原浓度和凝血活性。这些小鼠的循环FVIII重链多肽(442±151 ng mL-1与305±103 ng mL-1)和凝血活性(1.46±0.37 IU m-1与0.85±0.23 IU mL-1)相比增加。对照小鼠共同施用表达野生型FVIII的重链和轻链的双重载体。此外,凝血活性与接受单个表达FVIII(1.79±0.59 IU mL-1)的载体的小鼠的凝血活性相似。这些发现表明,通过链间二硫键的结合改善蛋白质的转拼是提高基于双载体的FVIII基因转移的功效的一种有前途的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号